Medicenna Therapeutics Corp.
NASDAQ:MDNA
0.157 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 33.596 | 20.535 | 30.375 | 22.698 | 2.371 | 3.939 | 14.038 | 5.339 | 0 | 0 |
Short Term Investments
| 0 | 0 | 10.01 | 15.003 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 33.596 | 20.535 | 40.385 | 37.7 | 2.371 | 3.939 | 14.038 | 5.339 | 0 | 0 |
Net Receivables
| 0.855 | 1.308 | 0.41 | 0.058 | 2.477 | 0.161 | 0.134 | 0.113 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0 | 1.548 | 0 | 0 | 0.258 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets
| 36.385 | 23.391 | 42.149 | 37.852 | 5.106 | 4.287 | 14.386 | 5.656 | 0 | 0.001 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0.032 | 0.068 | 0 | 0.002 | 0.004 | 0 | 0 | 0 |
Goodwill
| 0.061 | 0 | 0.071 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0.065 | 0 | 0.076 | 0.081 | 0.086 | 0.094 | 0.099 | 0 | 0 |
Goodwill and Intangible Assets
| 0.061 | 0.065 | 0.071 | 0.076 | 0.081 | 0.086 | 0.094 | 0.099 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
Total Non-Current Assets
| 0.061 | 0.065 | 0.103 | 0.144 | 0.081 | 0.088 | 0.098 | 0.099 | 0 | 0 |
Total Assets
| 36.446 | 23.456 | 42.252 | 37.996 | 5.187 | 4.375 | 14.483 | 5.755 | 0 | 0.001 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 1.617 | 1.672 | 2.245 | 0.456 | 0.802 | 0.877 | 0.487 | 0.359 | 0 | 0 |
Short Term Debt
| 0 | 0 | 0.034 | 0.035 | 0 | 0 | 0 | 1.459 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 2.183 | 0.949 | 1.828 | 1.324 | 1.594 | 0.998 | 6.863 | 1.692 | 0 | 0.001 |
Total Current Liabilities
| 3.8 | 2.621 | 4.107 | 1.815 | 2.396 | 1.876 | 7.349 | 3.51 | 0 | 0.001 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 0 | 0 | 0 | 0.032 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 1.672 | 0 | 0 | 0.174 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 3.16 | 1.672 | 0 | 0.032 | 0.174 | 0.337 | 0.477 | 0 | 0 | 0 |
Total Liabilities
| 6.96 | 2.621 | 4.107 | 1.847 | 2.571 | 2.213 | 7.826 | 3.51 | 0 | 0.001 |
Equity: | ||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 100.924 | 83.671 | 79.587 | 56.577 | 16.616 | 14.302 | 13.464 | 1.73 | 0.002 | 0.001 |
Retained Earnings
| -80.981 | -70.933 | -48.356 | -31.067 | -22.79 | -18.082 | -10.616 | -2.985 | -0.002 | -0.001 |
Accumulated Other Comprehensive Income/Loss
| 0.057 | 0.171 | 0.234 | 0.248 | 0.157 | 0.151 | 0.214 | 0.177 | 0 | 0 |
Other Total Stockholders Equity
| 9.486 | 7.926 | 6.68 | 10.39 | 8.633 | 5.79 | 3.595 | 3.322 | 0 | 0 |
Total Shareholders Equity
| 29.486 | 20.835 | 38.145 | 36.149 | 2.617 | 2.162 | 6.657 | 2.245 | -0 | -0 |
Total Equity
| 29.486 | 20.835 | 38.145 | 36.149 | 2.617 | 2.162 | 6.657 | 2.245 | -0 | -0 |
Total Liabilities & Shareholders Equity
| 36.446 | 23.456 | 42.252 | 37.996 | 5.187 | 4.375 | 14.483 | 5.755 | 0 | 0 |